Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Long-Term Safety and Tolerability Extension Study Evaluating Atogepant for the Prevention of Chronic or Episodic Migraine

ClinicalTrials.gov ID: NCT04686136

Public ClinicalTrials.gov record NCT04686136. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Nov 11, 2026, 7:52 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Multicenter, Open-Label 156-Week Extension Study To Evaluate The Long-Term Safety And Tolerability Of Oral Atogepant For The Prevention Of Migraine In Participants With Chronic Or Episodic Migraine

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This study will evaluate the Long-Term Safety and Tolerability of Atogepant 60 mg daily for the Prevention of Migraine in Participants with Chronic or Episodic Migraine

Study identification

NCT ID
NCT04686136
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
AbbVie
Industry
Enrollment
596 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Feb 19, 2021 (Actual)
Primary completion
Oct 20, 2025 (Actual)
Completion
Oct 20, 2025 (Actual)
Last update posted
Dec 18, 2025

2021 – 2025

United States locations

U.S. sites
42
U.S. states
24
U.S. cities
38
Facility City State ZIP Site status
Duplicate_Barrow Neurological Institute /ID# 228217 Phoenix Arizona 85013-4407 —
California Headache and Balance Center /ID# 226241 Fresno California 93720 —
Duplicate_Pharmacology Research Institute (PRI) - Los Alamitos (Wake) /ID# 226404 Los Alamitos California 90720-3500 —
Pharmacology Research Institute (PRI) - Newport Beach (Wake) /ID# 226389 Newport Beach California 92660 —
Excell Research, Inc /ID# 228390 Oceanside California 92056 —
Duplicate_Schuster Medical Research Institute /ID# 226246 Sherman Oaks California 91403 —
Alpine Clinical Research Center /ID# 226203 Boulder Colorado 80301-1880 —
Sensible Healthcare /ID# 226426 Ocoee Florida 34761 —
Accel Research Sites - Tampa Clinical Research Unit /ID# 226252 Tampa Florida 33634 —
NeuroTrials Research Inc /ID# 226477 Atlanta Georgia 30342 —
Allied Physicians - Fort Wayne Neurological Center /ID# 226390 Fort Wayne Indiana 46804 —
Josephson-Wallack-Munshower Neurology - Northeast /ID# 226295 Indianapolis Indiana 46256 —
Collective Medical Research /ID# 226482 Overland Park Kansas 66210 —
Ochsner Clinic Foundation /ID# 228220 Covington Louisiana 70433-8107 —
Pharmasite Research, Inc. /ID# 226444 Baltimore Maryland 21208 —
Beth Israel Deaconess Medical Center /ID# 228214 Boston Massachusetts 02215-5400 —
BTC of New Bedford /ID# 226289 New Bedford Massachusetts 02740 —
Clinical Research Institute, Inc /ID# 226232 Minneapolis Minnesota 55402-2606 —
Headache Neurology Research Institute /ID# 226234 Ridgeland Mississippi 39157 —
StudyMetrix Research /ID# 226296 City of Saint Peters Missouri 63303 —
Clinvest Research LLC /ID# 226275 Springfield Missouri 65807 —
Methodist Physicians Clinic/CCT Research /ID# 226422 Fremont Nebraska 68025 —
Albuquerque Clinical Trials, Inc. /ID# 226523 Albuquerque New Mexico 87102 —
Albany Medical Center Rheumatology /ID# 228212 Albany New York 12208-3412 —
Headache Wellness Center /ID# 226233 Greensboro North Carolina 27405 —
Duplicate_CTI Clinical Research Center /ID# 226278 Cincinnati Ohio 45212 —
Stetson-University of Cincinnati /ID# 226326 Cincinnati Ohio 45219 —
Abington Neurological Associates - Abington /ID# 226449 Abington Pennsylvania 19001 —
Preferred Primary Care Physicians, Inc. /ID# 226447 Pittsburgh Pennsylvania 15236 —
Mount Vernon Clinical Research /ID# 226249 Chattanooga Tennessee 37421 —
CNS Healthcare - Memphis /ID# 226254 Memphis Tennessee 38119 —
FutureSearch Trials of Neurology /ID# 226424 Austin Texas 78731 —
Austin Clinical Trial Partners /ID# 228391 Austin Texas 78737 —
DiscoveResearch, Inc /ID# 226490 Bryan Texas 77802 —
Texas Neurology /ID# 226425 Dallas Texas 75214 —
LinQ Research, LLC /ID# 226391 Pearland Texas 77584 —
J. Lewis Research, Inc. / Foothill Family Clinic /ID# 226248 Salt Lake City Utah 84109 —
J. Lewis Research, Inc. Foothill Family Clinic South /ID# 226328 Salt Lake City Utah 84121 —
Highland Clinical Research /ID# 226287 Salt Lake City Utah 84124 —
Sentara Family Medicine Physicians /ID# 226448 Virginia Beach Virginia 23456 —
Northwest Clinical Research Center /ID# 226240 Bellevue Washington 98007 —
Puget Sound Neurology /ID# 226253 Tacoma Washington 25328 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 74 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04686136, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 18, 2025 · Synced Nov 11, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04686136 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →